Endpoint Selection
Endpoint Selection is the process of identifying and specifying the primary and secondary outcomes that will be measured in a randomized controlled trial to evaluate the efficacy or safety of an intervention, distinguishing it from related design elements by its focus on defining the key variables that directly address the study’s research questions.
152
Publications
8.4K
Citations
983
Authors
551
Institutions
Publications per year
2017–2026
58
Variants
Outcome Selection
Parents
152
1–5 of 152
983
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 983
551
Harvard University
Cambridge, United States
10 h-index
22 publications
1.1K citations

Johns Hopkins University
Baltimore, United States
8 h-index
11 publications
258 citations

University of Toronto
Toronto, Canada
8 h-index
13 publications
777 citations
Mayo Clinic
Rochester, United States
6 h-index
39 publications
2.6K citations
Pfizer (United States)
New York, United States
6 h-index
10 publications
965 citations
University College London
London, United Kingdom
6 h-index
19 publications
852 citations
Stanford University
Stanford, United States
6 h-index
9 publications
227 citations
Novartis (Switzerland)
Basel, Switzerland
5 h-index
9 publications
331 citations
1–8 of 551
Repository · 8 publications · 385 citations
7
h-index
5 publications · 169 citations
5
h-index
5 publications · 285 citations
5
h-index
4 publications · 86 citations
4
h-index
4 publications · 166 citations
4
h-index
1–5